Skip to main content

Advertisement

Log in

Antineutrophil Cytoplasmic Antibody in Patients with Primary Sjo¨gren’s Syndrome

  • Short Communication
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract:

The incidence, specificity and clinical significance of positivity for serum antineutrophil cytoplasmic antibody (ANCA) was investigated in 60 patients with primary Sjögren’s syndrome (SjS). The indirect immunofluorescence (IIF) technique and an enzyme-linked immunosorbent assay (ELISA) were used to measure ANCA. Purified myeloperoxidase (MPO), lactoferrin (LF), cathepsin-G (CTG) and elastase (HLE) served as ANCA antigens for the ELISA. Ten (16.7%) of the 60 SjS patients showed positivity by IIF for perinuclear, but not cytoplasmic, ANCA. Four of the 60 sera were shown to be positive for LF, four for MPO, 0 for CTG and 0 for HLE by ELISA. There was no correlation between ANCA positivity and clinical features. ANCA in patients with SjS might be an epiphenomenon of polyclonal B-cell activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 22 July 1998 / Accepted: 10 December 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishiya, K., Chikazawa, H., Hashimoto, K. et al. Antineutrophil Cytoplasmic Antibody in Patients with Primary Sjo¨gren’s Syndrome. Clin Rheumatol 18, 268–271 (1999). https://doi.org/10.1007/s100670050100

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100670050100

Navigation